SNG vs. NSCI, OBI, OPTI, SBTX, ONC, OBD, BVX, IMM, DEST, and HEMO
Should you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include NetScientific (NSCI), Ondine Biomedical (OBI), OptiBiotix Health (OPTI), SkinBioTherapeutics (SBTX), Oncimmune (ONC), Oxford BioDynamics (OBD), BiVictriX Therapeutics (BVX), ImmuPharma (IMM), Destiny Pharma (DEST), and Hemogenyx Pharmaceuticals (HEMO). These companies are all part of the "biotechnology" industry.
Synairgen (LON:SNG) and NetScientific (LON:NSCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations.
Synairgen has a beta of -2.23, suggesting that its stock price is 323% less volatile than the S&P 500. Comparatively, NetScientific has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500.
Synairgen received 82 more outperform votes than NetScientific when rated by MarketBeat users. However, 69.61% of users gave NetScientific an outperform vote while only 56.46% of users gave Synairgen an outperform vote.
In the previous week, Synairgen's average media sentiment score of 0.67 beat NetScientific's score of 0.00 indicating that Synairgen is being referred to more favorably in the media.
28.6% of Synairgen shares are owned by institutional investors. Comparatively, 4.3% of NetScientific shares are owned by institutional investors. 3.1% of Synairgen shares are owned by company insiders. Comparatively, 40.1% of NetScientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
NetScientific has higher revenue and earnings than Synairgen. NetScientific is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks.
Synairgen has a net margin of 0.00% compared to NetScientific's net margin of -221.55%. NetScientific's return on equity of -21.43% beat Synairgen's return on equity.
Summary
Synairgen and NetScientific tied by winning 7 of the 14 factors compared between the two stocks.
Get Synairgen News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Synairgen Competitors List
Related Companies and Tools
